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A B S T R A C T   
The follicular route is an important drug penetration pathway in any topical application, either concerning 
dermatological and cosmetic skin treatments or any transdermal administration regimen. Efficient transport into 
follicles will depend on drug inherent properties but also on the chosen vehicle. The main study goal was to 
compare several systems for the delivery to the hair bulb of two fluorescent molecules of different water af-
finities: the hydrophobic Nile Red and the quite similar but hydrophilic Nile Blue. Three common nanoparticle 
types were compared in terms of encapsulation efficiency and stability: liposomes, ethosomes and polymeric 
nanoparticles. A liquid serum-like formulation was also developed, adjusting the final ethanol amount to the type 
of dye to be solubilized. Then, this formulation and the nanoparticle systems that successfully passed charac-
terization and stability stages were further studied on their ability to reach the bulb. The serum formulation was 
able to deliver, both drug models, to deeper follicular regions than nanoparticles. Attending to the envisioned 
zone target of the follicle, the simplest approach proved to be the best choice from all the systems tested in this 
work. Nonetheless, nanocarriers and the inherent complexity of their manufacturing processes may be justified 
under very specific requirements.   
1. Introduction 
Improved bioavailability of topically applied drugs has been a major 
pharmaceutical aim. Though skin seems an ideal therapeutic target 
organ by being easily accessible, usually not associated with increased 
plasma levels, gastrointestinal/enzymatic drug degradation, hepatic 
first pass metabolism neither with systemic toxicity and side effects, it is 
an amazing barrier (Patzelt and Lademann, 2020). Skin prevents the 
penetration of most topically applied drugs resulting in a general low 
bioavailability. 
In skin, hair follicles (HFs) are an important and promising pene-
tration pathway for dermatotherapy and they have been intensively 
investigated for more than 20 years (Lademann et al., 2008). HFs can be 
an efficient drug reservoir, creating the possibility for sustained drug 
delivery (Schafer-Korting et al., 2007). Indeed, the compounds and 
particles have a significantly longer storage time when they are inside 
HFs than when they stay trapped in the stratum corneum (Lademann 
et al., 2006). Besides their importance in topical drug administration, 
HFs can their selves be a treatment target: bulb, bulge or associated 
sebaceous glands. Follicular permeation and accumulation of topically 
applied substances is particularly critical for the efficacy of skin medical 
and cosmetic treatments (Ossadnik et al., 2006). The HFs occupy <0.1% 
of total skin surface area, however, on scalp and face regions, they can 
be as much as 10% of total skin area (Fang et al., 2014; Wosicka and Cal, 
2010). The region of the infundibulum on HFs increases the body surface 
area and interrupts the epidermal barrier towards the lower parts of the 
HF, serving as an entry access for drug delivery (Fang et al., 2014). 
Efficient drug transport into the HFs depends upon the interaction 
between the drug and the sebum as well as the choice of the drug vehicle 
(Blume-Peytavi and Vogt, 2011). Nanotechnology is a modern and 
quickly evolving trend in dermal, transdermal and follicular drug de-
livery; there are a huge variety of nanocarriers, including liposomes, 
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nano-formulations, nanocrystals, polymeric nanoparticles, among 
others (Czajkowska-Kośnik et al., 2019). General advantages of 
nanoparticle-based topical delivery systems are the transport of 
increased drug concentrations, better solubility of hydrophobic drugs, 
increased chemical and physical stability and both sustained and 
controlled release of the cargo (Patzelt and Lademann, 2020). In fact, 
nanoparticles can improve the stability of several molecules (Morganti, 
2010; Rosen et al., 2015), promote their accumulation in the follicular 
opening and enhance their permeation along the follicular duct. Besides 
clinical applications, drug encapsulation systems are also key tools on 
the development of new cosmetic products. Cosmetic products are 
chemically complex formulations where the long-term stability of in-
gredients is a major issue. 
There are several reported studies that analyze the skin and follicular 
permeation of drug delivery systems (Abd et al., 2018; Blume-Peytavi 
et al., 2010; Lauterbach and Müller-Goymann, 2015; Ossadnik et al., 
2006; Patzelt et al., 2011; Teichmann et al., 2007). Recently, some 
nanocarriers were developed to deliver topically drugs with interesting 
potential to treat acne vulgaris, hidradenitis suppurativa, androgenic 
alopecia and inflammation-based skin and hair disorders (Angelo et al., 
2020; Pereira et al., 2021; Tolentino et al., 2021; Ushirobira et al., 
2020). The authors have compared the developed vehicles with com-
mercial ones or with the drug in solution and they have elegantly 
quantified which percentage of the drug penetrated into the skin spe-
cifically through the follicular pathway (Angelo et al., 2020; Pereira 
et al., 2021; Tolentino et al., 2021; Ushirobira et al., 2020). The different 
nanoparticles and nanocapsules all promoted the targeting of the HFs 
regarding the other non-structured vehicles. Most of the research done 
in the area of topical drug administration, using either nanocarriers or 
vehicle formulations, is designed to deliver the cargo into the systemic 
circulation, to skin layers using the follicular route (thus avoiding the 
stratum corneum barrier) or to particular follicle regions not as deep as 
the bulb. With this work we aimed to deliver molecules with different 
water affinities to the bulb region of hair follicles. Hair bulbs contain the 
cell populations responsible for the production, morphology and 
pigmentation of the hair fiber and therefore are important cosmetic 
targets (Knorr et al., 2009; Wosicka and Cal, 2010). Our approach 
consisted in comparing the performance of different but common ve-
hicles for structurally very similar cargos: two fluorescent molecules, 
one being used as a model for hydrophilic and the other as a model for 
hydrophobic compounds. Three different drug encapsulation systems - 
liposomes, ethosomes, and polymeric nanoparticles - and a new devel-
oped formulation were compared. The formulation was developed as a 
scalp serum with common cosmetic ingredients in which the solubility 
of the two fluorescent dyes was attained with different amounts of 
ethanol. First, we characterized the physical properties of each partic-
ulate system and their stability over time. The particles that were most 
suited to encapsulate the model molecules and that remained stable over 
several months of storage were further studied in terms of hair follicle 
penetration and compared to the serum-like formulation. We studied 
qualitatively the skin and HF penetration profile of the model molecules 
using ex vivo porcine skin, still considered one of the best human skin 
models (Lauterbach and Müller-Goymann, 2015). 
2. Materials and methods 
2.1. Chemicals and solvents 
The materials Poly (D,L-lactide) (PLA) (Mw = 18–24 kDa), Plur-
onic® F68 (suitable for cell culture), Nile Blue (NB, Basic Blue 12) (Mw 
= 732.8 g/mol; predicted LogP = 0.7 according to Molinspiration 
Cheminformatics free web services, https://www.molinspiration.com, 
Slovensky Grob, Slovakia) and cholesterol were purchased from Sigma- 
Aldrich (Sigma Chemical Co., St. Louis, MO, U.S.A.). Nile Red (NR, Nile 
Blue oxazone) (Mw = 318.4 g/mol; predicted LogP = 4.58 according to 
Molinspiration Cheminformatics free web services, https://www. 
molinspiration.com, Slovensky Grob, Slovakia) was purchased from 
TCI (Tokyo Chemical Industry Co., Ltd., Tokyo, Japan). 2-Propanol was 
purchased from Fisher Scientific (Hampton, NH, U.S.A). 1,2-dioleoyl-sn- 
glycero-3-phosphoethanolamine (DOPE), and 1,2-distearoyl-sn-glycero- 
3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000] (DSPE- 
mPEG) were purchased from Lipoid GmbH (Ludwigshafen am Rhein, 
Germany). Acetone and ethanol were of the highest grade commercially 
available and purchased from several suppliers. 
2.2. Preparation of the delivery systems 
Three drug encapsulation systems were prepared: two lipid-based 
nanocarriers and PLA nanoparticles (PLA NPs). By mixing four com-
mon commercial cosmetic ingredients, a non-particulate serum, profiled 
as a scalp serum, was obtained in collaboration with subcontractor 
company - Inovapotek, Pharmaceutical Research and Development, Lda. 
(Porto, Portugal). 
PLA NPs were prepared using the nanoprecipitation protocol 
described by Fernandes et al. (Fernandes et al., 2015). Firstly, the 
polymer was dissolved in a mixture of ethanol and acetone (50:50, v/v) 
at a concentration of 2% (w/w). Then, under magnetic stirring, one 
volume of the organic phase was added to two volumes of an aqueous 
phase containing 0.6% (w/w) Pluronic® F68. After nanoparticles have 
formed, the organic phase was completely removed with a rotary 
evaporator. The aqueous suspensions of nanoparticles, containing 
approximately 0.8% PLA, (w/w) were stored at 4 ◦C. PLA NPs loaded 
with the fluorescent dyes (final concentration of 100 µg/ml) were ob-
tained as above by dissolving NR in the organic phase or NB in the 
aqueous phase. Care was taken to avoid exposure to light throughout all 
the experimental procedures involving the fluorescent dyes. 
Liposomes were prepared with the modified ethanol injection 
method described by Guimarães et al. (Guimarães et al., 2020), using 
DOPE, cholesterol and DSPE-mPEG at a molar ratio of 5.4 : 3.6 : 1, 
respectively. Briefly, these components were first dissolved in ethanol 
and one volume of the ethanolic solution was injected under agitation 
(500 rpm) into one volume of the aqueous phase [phosphate-buffered 
saline (PBS), pH 7.4, 70 ◦C]. The encapsulation of dyes was attained 
by solubilizing them in the organic or aqueous phase, as described for 
the preparation of PLA NPs. The liposomal formulations were kept under 
agitation, at 70 ◦C, to evaporate the organic phase. Afterwards, PBS was 
added to achieve a final concentration of 1.31% (w/w) DOPE, 0.45% 
(w/w) cholesterol and 0.91% (w/w) DSPE-mPEG. The prepared lipo-
somal formulations were stored at 4 ◦C. 
Ethosomes were prepared using the same methodology as described 
for liposomes, but, when adjusting the final concentration of particles 
with PBS, ethanol was added to a final concentration of 10% (v/v). 
To remove the free dye in all particulate systems, the suspensions 
were passed through a gel filtration chromatography column with a 5 
kDa cut-off (PD-10 Desalting Columns containing 8.3 mL of Sephadex™ 
G-25 Medium; GE Healthcare, IL, U.S.A.). The separation was performed 
according to the supplier’s instructions. The columns were equilibrated 
with water, PBS or 10% (v/v) ethanol in PBS, according to the type of 
particles, i.e., PLA NPs, liposomes or ethosomes; the collected particle 
suspensions were 1.4 times more diluted than before gel filtration. 
The serum-like formulation - consisted of an aqueous mixture of 
denatured ethanol, a preservative, a permeating and a thickener. Two 
formulations were developed taking into account the fluorescent mole-
cule needed to be stably solubilized in it. Both contained 0.1% (v/v) 
Lecigel™ (used as emulsifier, penetration enhancer and gelling agent), 
1% (v/v) Euxyl® PE9010 (used as preservative) and 4% (v/v) Trans-
cutol® CG (used as penetration enhancer). In the formulation containing 
40 µg/mL NB, the final concentration of ethanol was set at 10% (v/v). In 
the formulation containing 40 µg/mL NR, the final concentration of 
ethanol was set at 53% (v/v). 
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2.3. Particle size and size distribution 
The mean size (nm) and polydispersity (PDI, index from 0.0 to 1.0) of 
purified PLA NPs, liposomes and ethosomes were assessed by Photon 
Correlation Spectroscopy (PCS). All measurements were performed at 
25 ± 1 ◦C, using a ZetaSizer Nano ZS equipment (Malvern Instruments 
Ltd, Worcestershire, U.K.). The physical stability of suspensions was 
evaluated over 6 months, by measuring the size and PDI of all nano-
particles stored at 4 ◦C. 
2.4. Entrapment efficiency determination 
The liposomes and ethosomes were lysed with isopropanol. The PLA 
NPs were lysed with acetone. The encapsulated dye in all particulate 
systems was assessed by Ultraviolet (UV)-Spectrophotometry. For NR- 
loaded PLA NPs, measurements were performed with an excitation 
wavelength at 536 nm and emission wavelength at 608 nm. For NB- 
loaded PLA NPs, 499 nm and 596 nm were used as excitation and 
emission wavelengths, respectively. For NR-loaded liposomes or etho-
somes, measurements were performed with an excitation wavelength at 
552 nm and emission wavelength at 635 nm. For NB-loaded liposomes 
or ethosomes, 635 nm and 680 nm were used as excitation and emission 
wavelengths, respectively. The amount of dyes was determined using 
calibration curves. The percentages of entrapment efficiency (EE %) 
were calculated with respect to the initial dye amount present in the 
non-purified suspensions of nanoparticles, according to the following 
equation (1): 
EE% =
[mass of dye in nanoparticles]
[initial mass of dye]
× 100 (1) 
The entrapment efficiencies were reevaluated periodically over 6 
months storage at 4 ◦C, to infer about the chemical stability of 
compound-loaded nanoparticles suspensions. Before each evaluation, 
the suspensions were filtrated again, as described before, to remove free 
dyes. 
The percentages of loading efficiency (LE %) were also calculated 
with respect to the amount of lipids or polymer used in the preparation 
of nanoparticles, according to the following equation (2): 
LE% =
[mass of dye in nanoparticles]
[mass of nanoparticles]
× 100 (2)  
2.5. Ex vivo HF penetration and distribution assay 
The porcine skin samples were excised from the abdominal region of 
freshly slaughtered pigs. Approval for these experiments was obtained 
from the Portuguese competent authority, the Direção Geral de Veter-
inária. Pre-treatment of porcine skin included a rinse under running tap 
water, a careful removal of subcutaneous fat, and a final rinse with 
sterile PBS (pH 7.4). Skin pieces were placed with the stratum corneum 
facing the donor compartment and the dermis facing the receptor 
compartment of Franz Diffusion Cells with a diffusional area of 0.64 cm2 
(PermeGear Inc., Bethlehem, PA, U.S.A.). After tissue acclimatization to 
the receptor phase (PBS, pH 7.4, thermostatically maintained at 37 ◦C), 
300 µL of each dye-loaded NPs suspension or serum-like formulation 
were applied, in a single dose, to the skin surface. The experiments were 
conducted for 24 h with at least 2 replicates. After 24 h, the skin samples 
were rapidly washed and quickly frozen in optimal cutting temperature 
compound (OCT medium, Thermo Fisher Scientific, Waltham, MA, U.S. 
A.) and kept at − 80 ◦C. Histological cuts of 20 µm thickness were made 
using a Leica CM1900 cryostat (Leica Microsystems, Numsloch, Ger-
many). Each sample resulted in, at least, 50 histological sections. The 
penetration and distribution of the fluorescent dyes were investigated in 
skin sections by brightfield and fluorescence microscopy (Olympus 
BX51 Microscope; Olympus Corporation, Tokyo, Japan). The exposure 
times used were defined respecting the maximal exposure times of his-
tological sections from control samples at which there was a complete 
absence of skin auto fluorescence. Control samples were ex vivo porcine 
skin pieces treated with empty NPs systems and scalp serum formula-
tion, under the same conditions as previously described. 
2.6. Statistical analysis 
All the results are expressed as mean value ± standard deviation (SD) 
of at least three experiments. GraphPad Prism, version 8 (GraphPad 
Software, CA, U.S.A.) was used to perform the statistical analysis of the 
experimental data, using analysis of variance (ANOVA) and unpaired 
Student t-test. The differences were considered significant at p-values ≤
0.05. 
3. Results and discussion 
In view of the topical delivery of hydrophobic and hydrophilic 
bioactive molecules to the hair bulb, the work started with the prepa-
ration and characterization of several particulate vehicle systems. For 
the selection of the best systems, the considered criteria were their 
ability to encapsulate the chosen model molecules, the stability of that 
encapsulation as well as the physical properties of the particles. 
Achieving the bulb of the HFs is of major interest for us, since it is the 
region where hair fiber synthesis and its natural phenotype setting 
occur. 
3.1. Preparation and characterization of the particulate delivery systems 
Table 1 summarizes the average size and size distribution of the 
prepared empty and dye-loaded NP systems. The particle Z-average 
values for both lipid-based systems are very similar, while for PLA NPs 
they are slightly higher; all values are in the range of sizes obtained 
before (Fernandes et al., 2015; Guimarães et al., 2020). A tendency for 
particle shrinkage or enlargement is also observed in all tested systems 
when loaded with NR or NB, respectively; the only exception concerns 
the NB-loaded ethosomes, that maintained their size. Regarding the 
polydispersity, the values obtained are very low and all the produced 
systems can be considered monodispersed. Nonetheless, the PLA NPs 
present the greatest size homogeneity. Although significant differences 
were detected statistically, in practical terms, they would not noticeably 
interfere with the ability of nanoparticles to penetrate into and along the 
follicle. 
Table 1 
Size and size distribution for empty and dye-loaded particles under study, after being purified by gel filtration chromatography. NB – Nile Blue; NR – Nile Red; PLA NPs 
– Poly (D,L-lactide) nanoparticles. Data were analyzed by one-way ANOVA, followed by post-hoc Tukey’s test. The letters refer to the comparisons within each type of 
particles. The symbols refer to the comparisons between particles. Means that do not share a letter or a symbol are significantly different, p ≤ 0.05.   
Dye Liposomes Ethosomes PLA NPs 
Z-average ± SD (nm) – 128 ± 2 a* 131 ± 4 a* 165.1 ± 0.6 a+
NR 121.8 ± 0.4 b* 124 ± 6 a* 148 ± 1 b+
NB 138 ± 3 c* 125 ± 2 a+ 176 ± 2 c∅ 
PDI ± SD – 0.118 ± 0.001 a* 0.108 ± 0.005 a+ 0.095 ± 0.004 a∅ 
NR 0.114 ± 0.004 ab* 0.103 ± 0.008 a*+ 0.086 ± 0.008 a+
NB 0.107 ± 0.005 b* 0.131 ± 0.007 b+ 0.084 ± 0.003 a∅  
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Liposomes are vesicular structures with an aqueous core surrounded 
by a lipid bilayer membrane of non-toxic and biodegradable phospho-
lipids (Bozzuto and Molinari, 2015; Ghanbarzadeh and Arami, 2013). 
They are widely studied for their ability to encapsulate both hydrophilic 
and lipophilic drugs, becoming a potential vehicle to deliver bioactive 
molecules into specific target sites with very promising results. In the 
particular case of HFs, the phospholipids of liposomes can assist the 
interaction with sebum and subsequently facilitate the entrance and 
delivery to this skin appendage (Jung et al., 2006; Kumar and Banga, 
2016; Santos et al., 2018). 
Ethosomes can have some advantages over liposomes in topical de-
livery. The ethanol per se has the ability to enhance the permeability of 
several compounds (both hydrophobic and hydrophilic) after topical 
application and improve their follicular penetration. Ethanol can 
interact with sebum and increase its fluidity just enough to enable a 
more effective penetration of the applied substances (Pilch and Musiał, 
2018; Sala et al., 2018). Ethanol can also increase the flexibility and 
softness of liposomes and decrease their sizes (Fang et al., 2014; 
Ghanbarzadeh and Arami, 2013). In the present work, the concentration 
of ethanol used to produce the ethosomes did not affect the size of the 
particles with the chosen composition described in the methods section. 
The amount of ethanol applied to the liposomes was used in order to 
improve their follicular penetration. 
Nanoparticles of PLA were also studied, already knowing their high 
potential for delivering compounds deeply into HFs (Fernandes et al., 
2015). PLA is characterized as a linear, lipophilic, biodegradable poly-
mer. The constituting monomer, D,L-lactic acid, can be easily obtained 
from renewable sources as the sugarcane or corn starch. Lactic acid is the 
primary degradation product of the complete polymer hydrolysis, which 
makes PLA of great interest for numerous applications (Rancan et al., 
2009). The prepared PLA NPs presented a slightly higher size compared 
to the conventional liposomes and ethosomes; this size range obtained 
for PLA NPs is in accordance with Fernandes et al., these nanoparticles 
were capable of reaching the HFs bulbs (Fernandes et al., 2015). 
Several reports in the literature state that it is possible to do a se-
lective targeting of a particular structure or region within the HF by 
tuning the particle diameter (Rancan et al., 2009; Vogt et al., 2005; 
Wosicka and Cal, 2010). Indeed, it was already demonstrated by some 
authors, that the penetration depth increases within the follicular duct 
with decreasing size of the nanoparticles (Papakostas et al., 2011; Vogt 
et al., 2006). In addition, if nanoparticles are larger than 100 nm they 
will not translocate to other viable skin layers and will be confined in-
side the follicle duct (Rancan et al., 2009). According to the average 
sizes here obtained, all the prepared particles are below 200 nm which is 
an ideal size according to the work purpose. Regarding size distribution, 
all of the prepared NPs showed an even distribution with high homo-
geneity (<0,140). According to Danaei et al., values of PDI < 0.2 are 
usually considered acceptable for polymeric NPs (Danaei et al., 2018). 
For lipid-based nanocarriers, a PDI < 0.3 is considered to be tolerable 
and designates a homogenous population (Badran, 2014; Chen et al., 
2011; Putri et al., 2017). All the systems produced in this work possess 
adequate particle size and size distributions for topical follicular de-
livery of the model compounds, targeting the bulb. 
3.2. Entrapment efficiency of model compounds 
Two fluorescent dyes with very similar structures but with distinct 
water affinities were chosen in order to better evaluate the influence of 
the hydro- and lipophilic characters of the cargo on the entrapment ef-
ficiency and stability of NPs. Being fluorescent just serves the purpose of 
histological detection to study cargo penetration and distribution into 
the HF structure after topical application. In this sense, NB and NR were 
used as models of lipophilic and hydrophilic compounds, respectively. 
These dyes have good photostability and they can be incorporated into 
diverse materials or onto surfaces where they act as a light/pH sensors 
for various applications (Martinez and Henary, 2016). The NR molecule 
is intensely fluorescent in apolar media. However, in water, it is 
extremely poorly soluble (hydrophobic feature), and it does not show 
any fluorescence. NB is a cationic fluorescent molecule and thus, more 
readily soluble in water than NR (hydrophilic feature) (Martinez and 
Henary, 2016). Moreover, NR has its emission in the red region of the 
light spectrum, the region where skin shows low auto-fluorescence 
(Rancan et al., 2009), and NB, compared to NR, has a redshift in the 
absorbance spectrum making it even a better candidate for biological 
imaging (Martinez and Henary, 2016). 
The results of dye encapsulation by the different lipid-based ap-
proaches are shown in Table 2. The encapsulation of both dyes into li-
posomes and ethosomes proved to be highly efficient. Around 100% of 
each dye was entrapped into these lipid nanoparticles, meaning that the 
two types of lipid-based particles are able, in theory, to transport both 
dyes. Besides, their loading efficiencies are also similar. 
In this work, the entrapment efficiencies of the dyes by PLA NPs were 
around 30% for NB and around 10% for NR, considerably lower values 
compared to those obtained with lipid-based nanoparticles (Table 2). 
Such low EE can be related to the saturation of the system. If the initial 
amount of dyes used to prepare the dye-loaded PLA NPs was adjusted to 
near or below what seems to be the maximal entrapment capacity of 
those particles (Fernandes et al., 2015), the EE values would certainly be 
improved. Despite the low encapsulation efficiency, the theoretical 
loading efficiency of NB is very similar to the lipidic systems: ≈ 0.38 mg 
of encapsulated dye per 100 mg of polymer used in the preparation of 
nanoparticles. Furthermore, the NR-loaded PLA NPs prepared in this 
work, had a loading efficiency higher than the one previously obtained 
for these nanoparticles with this specific fluorescent molecule (Fer-
nandes et al., 2015). 
3.3. Stability of particulate delivery systems 
The dye content of all prepared NPs was evaluated over 6 months of 
storage at 4 ◦C (Fig. 1). 
For the lipid-based particles, the EE stability depends on the 
entrapped dye; PLA NPs were resilient to the hydro- and lipophilicity 
character of the dye (Fig. 1). The liposomes prepared with NR lost more 
than 60% of the dye content after 3 months; the lost amount did not 
significantly change after three more months (6 months in total). 
Although they kept the stability parameters of size and PDI (Table A.1) 
between acceptable levels, they were not able to retain the initial 
Table 2 
Entrapment and loading efficiencies of the dye-loaded particles under study, after being purified by gel filtration chromatography. NB – Nile Blue; NR – Nile Red; PLA 
NPs – Poly (D,L-lactide) acid nanoparticles. Data were analyzed by unpaired t-test for comparison within each type of vehicle and by one-way ANOVA, followed by 
post-hoc Tukey’s test for comparison between vehicles. The letters refer to the comparisons within each type of particles. The symbols refer to the comparisons between 
particles. Means that do not share a letter or a symbol are significantly different, p ≤ 0.05.   
Dye Liposomes Ethosomes PLA NPs 
Entrapment Efficiency (%) NR 107 ± 5 a* 95.9 ± 0.7 a* 11.07 ± 0.01 a+
NB 100 ± 3 a* 95 ± 10 a* 30.55 ± 0.03 b+
Loading Efficiency (%) NR 0.39 ± 0.02 a* 0.350 ± 0.003 a* 0.1384 ± 0.0001 a+
NB 0.37 ± 0.01 a* 0.35 ± 0.04 a* 0.3819 ± 0.0004 b*  
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amount of dye. Nonetheless, it is important to emphasize that encap-
sulation and its stability depend on the physicochemical properties of 
both cargo and vehicle compounds, whatever the particulate system. 
Ethosomes loaded with NR presented the same issues detected for li-
posomes. They lost most of the initial dye amount, maintaining only 
about 30% of the dye after 6 months. Despite this, as for NR-loaded li-
posomes, NR-loaded ethosomes were also able to maintain their size and 
PDI parameters over the 6 months, with non-significant differences 
(Table A1). 
In contrast to NR, a higher NB content was retained in liposomes; 
after a storage period of 6 months, liposomes contained more than 80% 
of the initial NB amount and they were also more stable in terms of size 
and size distribution (Table A1). Similar results were observed for NB- 
loaded ethosomes, where only a low percentage of dye was also lost 
and an increase in particles size (≈ 35 nm) was verified at the end of the 
storage period. In this way, both lipid-based systems loaded with the 
hydrophilic NB were chosen for subsequent ex vivo permeation studies. 
Further optimizations for the NR-loaded liposomes and ethosomes 
must be performed in order to increase their physical stability. However, 
the investment of time and effort needed was out of the scope of this 
work. These optimizations could, for example, involve the adjustment of 
the initial NR concentration as well as optimizing the proportion of lipid 
constituents. 
Although the PLA NPs presented low NR and NB entrapment effi-
ciencies, they were able to stably retain the initial amount of encapsu-
lated dyes throughout the 6 months (Fig. 1). Dye-loaded PLA NPs 
Fig. 1. Entrapment efficiencies of all particle systems for NR and NB, tested over 6 months. Data were analyzed by one-way ANOVA, followed by post-hoc Dunnett’s 
test. ****p ≤ 0.0001, compared with the time point 0 months; ns = not significant. 
Fig. 2. Brightfield (left) and fluorescence (right) images of stratum corneum (A) and hair follicles (B) of cross-sectioned porcine skin, after 24 h of treatment with a 
scalp serum formulation containing the fluorescent molecule Nile Red (Bar = 100 µm, 30 ms of exposure). 
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slightly change its size keeping its PDI stable (Table A1). But, due to the 
low amount of the dyes encapsulated, the PLA NPs were not further 
studied. 
The dye-encapsulation NP systems that presented the desired mini-
mum stability were selected for further experiments. They were applied 
topically to ex vivo porcine skin and qualitatively compared with the 
serum-like formulation in terms of skin permeation profile. 
3.4. Penetration and distribution of model compounds in ex vivo porcine 
skin 
The skin distribution and follicular penetration depth of the topically 
applied fluorescent dyes, carried by drug encapsulation NPs systems and 
formulation, were assessed on ex vivo porcine skin (Figs. 2-5). Porcine 
skin has been considered a good and suitable skin model and has been 
extensively used to study the skin permeation since it resembles human 
skin regarding its biochemical composition, thickness, as well as, its 
permeability properties (Hammond et al., 2000; Lauterbach and Müller- 
Goymann, 2015; Mittal et al., 2013; Simon and Maibach, 2000). For the 
analysis of follicular penetration and dye distribution in porcine skin 
cryo-sections, the exposure times were defined based on the absence of 
fluorescence in histological sections of control skin samples (Fig. A.1). 
In the experiments here described, the most stable dye-loaded NPs 
were used, prepared according to the established protocols in our 
research group: the NB-loaded liposomes and ethosomes. Regarding PLA 
NPs, the results of NR-loaded PLA from Fernandes et al. were used for 
comparison in terms of HF penetration depth (Fernandes et al., 2015). 
Drug non-encapsulation systems are commonly used in cosmetic 
products for the most diverse purposes. Based on a combination of 
suitable ingredients (Regulation EC No 1223/2009 of the European 
Parliament and of the Council of 30 November 2009 on cosmetic 
products,Official Journal of theEuropean Union; Buzek and Ask, 2009), 
these systems are easily prepared and approved for commercial use. 
Besides, they are in general stable as well as easily modifiable according 
to their purpose. In the scalp serum-like formulation, the amount of 
ethanol was adjusted according to the dye to be solubilized. However, 
the efficiency of such prepared systems is determined by their ability to 
deliver the cargo to the pretended target. 
The permeation results of the NR when carried by the formulation 
are exemplified in Fig. 2. Besides the stratum corneum, fluorescence is 
detected along the entire follicular duct, the sebaceous glands, reaching 
the region of the bulb. When carried by this particular system, the hy-
drophobic NR is able to permeate deeply the HF and it localizes in the 
more lipidic environment of skin and HF. These results correlate well 
with the results obtained by Fernandes et al., when a drug encapsulation 
NP system was used to deliver the same hydrophobic molecule and the 
bulb region was also reached (Fernandes et al., 2015). In both studies, 
massage was not used (Lademann et al., 2011; Radtke et al., 2017). As 
known, skin and its appendage are more permeable to hydrophobic 
molecules then to hydrophilic ones. Therefore, one can expect that a 
formulation will succeed in the delivery of drugs that inherently already 
have a good permeation profile. 
Based on the fact that the serum-like formulation and PLA NPs per-
formed similarly in terms of follicular depth attained for this model 
molecule (NR), it can be said that the formulation is more advantageous. 
Its advantages are related to an easier preparation methodology that, 
when industrial production is desirable, has a huge impact on 
manufacturing costs. 
Being more “water-friendly” than NR, more inherent difficulties 
could be foreseen in NB penetration along the follicular duct. On the 
other hand, in more hydrophobic media, NB has lower quantum yields 
than NR, being considerably more difficult to observe its fluorescence. In 
spite of these drawbacks, the penetration of NB can be observed along 
the HF till the region below the infundibulum (Fig. 3). Just a small 
amount of the dye seemed to be trapped in the stratum corneum and, as 
no fluorescence was detected in other skin layers, it does not reach the 
viable dermis in detectable amounts. The hair bulb does not show 
fluorescence (data not shown), meaning that with these nanoparticles, 
Fig. 3. Brightfield and fluorescence images of stratum corneum (A) and hair follicles (B) of cross-sectioned porcine skin, after 24 h of treatment with Nile Blue-loaded 
liposomes (Bar = 200 µm, 800 ms of exposure). 
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NB did not reach the deepest region of the HF in detectable amounts. In 
fact, lipid-based particles are most studied for transdermal (Ashtikar 
et al., 2016; Ghanbarzadeh and Arami, 2013) or transfollicular appli-
cations (Jung et al., 2006; Serrano et al., 2015; Verma et al., 2016). To 
carry out their function as a transfollicular delivery system, it is enough 
that these particles reach the infundibulum region. This region is known 
as an area of additional absorption; in this follicle region there is an 
interruption, due to the continuous loss of epidermal differentiation, and 
it is supplied by a dense capillary network, which facilitate the trans-
follicular permeation of some substances (Blume-Peytavi and Vogt, 
2011; Patzelt et al., 2011). Liposomes are also studied for the treatment 
of acne (Kumar and Banga, 2016), being sufficient that they reach the 
sebaceous glands. As these results are in line with the literature, lipo-
somes will be more appropriate when targeting certain regions of the 
Fig. 4. Brightfield (left) and fluorescence (right) images of cross-sectioned porcine skin, after 24 h of treatment with Nile Blue-loaded ethosomes (Bar = 200 µm, 800 
ms of exposure). 
Fig. 5. Brightfield (above) and fluorescence (below) images of stratum corneum (A) and hair follicle (B) of cross-sectioned porcine skin, after 24 h of treatment with a 
scalp serum formulation containing Nile Blue (Bar = 200 µm, 800 ms of exposure). 
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follicle not as deep as the bulb region. 
Ethanol acts as a skin permeation enhancer, however, this effect 
heavily depends on the drug and vehicle in question (Carreras et al., 
2020; Williams and Barry, 2012). According to Fig. 4, NB transported by 
ethosomes was found in follicular ducts of porcine skin after topical 
application, but it did not reach the bulb region. This permeation profile 
was similar to the one observed for NB when carried by liposomes. 
Nanoparticles in general can be used for specific targeting of HFs 
(Fang et al., 2014; Lademann et al., 2008), since they can preferentially 
accumulate in the HFs while they cannot permeate the stratum corneum 
(Papakostas et al., 2011). Still, their tendency to accumulate in the 
follicular orifice may block the particles penetration into a deeper region 
of the follicular duct (Tran et al., 2017; Vogt et al., 2014). This occlusion 
effect could be present on the permeation results obtained for the lipid 
NPs (Figs. 3-4). As with liposomes, ethosomes are also extensively 
studied for transdermal applications (Monisha et al., 2019; Nainwal 
et al., 2019). One study evaluated ethosomes as a delivery vehicle for the 
pilosebaceous unit, however this formulation favors skin permeation 
and not its accumulation or transport along the follicle (Wilson et al., 
2017). 
Particle aggregation and penetration occlusion are not an issue 
regarding the serum-like formulation. In Fig. 5, a more uniform NB 
fluorescence is seen along the entire HF, and specifically in the follicular 
bulb (Fig. 5B). Comparing to ethosomes or liposomes, the serum-like 
formulation delivers NB deeper than the tested NP systems after 
topical application in ex vivo porcine skin. Moreover, as noted for drug 
encapsulation systems, no fluorescence was detected in viable skin 
layers, the formulation was trapped in the stratum corneum which in-
dicates HF selective delivery (Fig. 5A). 
Looking at the qualitative results obtained with this comparative 
study, the serum-like formulation, developed for topical scalp applica-
tion, performed better than the tested NP systems for NB, here used as a 
hydrophilic model molecule. In agreement with the particular aim of 
selectively target the hair bulb, as more independently of cargo hydro-
philicity as possible, our choice lays on the formulation. However, a 
more complete picture must be obtained in future research by per-
forming a quantitative approach to the amount of cargo that was indeed 
penetrating into the stratum corneum, hair follicles and viable skin, for 
each vehicle (Oliveira et al., 2020; Pereira et al., 2021; Tolentino et al., 
2021). 
Thought NPs are a hot topic, even within our research group, they 
must be selected as delivery system under specific requirements, e. g., 
when the target compound is unstable or when targeting a specific 
population of cells (Alsalhi et al., 2020; Jeong et al., 2019). However, in 
these situations, it will be necessary to carry out a whole set of optimi-
zations depending on the particular molecule to be encapsulated. 
Serum-like formulations are less demanding in terms of optimization. 
Regarding this study and the model dyes used, the serum-like formula-
tion was easily tuned for the delivery of both hydrophilic and hydro-
phobic molecules, in this case, to hair bulbs. However, other hydrophilic 
and lipophilic molecules should be also investigated, in order to better 
assess the “plasticity” and potential of this serum-like formulation as a 
HF delivery vehicle. 
4. Conclusion 
Drug delivery to the HFs has been under the research spotlight for the 
past two decades. The HFs offer new opportunities not only concerning 
HF associated diseases but also for specific therapies like immuno- and 
gene therapies, and for the development of new targeted cosmetics 
(Patzelt et al., 2008). In this work, our purpose was to reach a distinct 
follicle zone – the bulb. The hair bulb is a very important therapeutic and 
cosmetic target site of HFs. During the growth stage of the hair cycle, the 
bulb is the factory of the shaft, that under genetic control produce and 
give color to the hair. Hair bulb cells and their expressed genes and 
proteins are implicated on hair morphology determination and for that 
reason they are very appealing targets of innovative cosmetics. Ac-
cording to the work purpose, mapping the delivery to the bulb turn the 
histological evaluation unavoidable and essential. It was not so much 
the dye quantity that reaches the follicle that we were first interested in, 
but rather knowing whether it reaches the bulb or not. Hereafter, the 
obtained results are promising and leverage a quantitative evaluation of 
the cutaneous versus follicular pathways used by the different systems 
and their validation in human skin. 
When the intention is to topically deliver substances to the HF, NPs 
are an obvious choice due to their intrinsic ability to penetrate and 
accumulate in HFs. This study proposes that scalp serum formulations 
must also be taken into consideration. Depending on the desired pur-
pose, these systems have several advantages over particles: their prep-
aration method is normally faster and easier; their composition can be 
easily modified and adjusted according to the molecule or molecules to 
be incorporated, and the scale up to industrial production is much faster 
with lower costs than for drug encapsulation nanosystems. 
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Gelfuso, G.M., Taveira, S.F., Gratieri, T., 2018. The role of formulation and follicular 
pathway in voriconazole cutaneous delivery from liposomes and nanostructured 
lipid carriers. Colloids Surfaces B Biointerfaces 170, 341–346. https://doi.org/ 
10.1016/j.colsurfb.2018.06.037. 
Schafer-Korting, M., Mehnert, W., Korting, H.-C., 2007. Lipid nanoparticles for improved 
topical application of drugs for skin diseases☆. Adv. Drug Deliv. Rev. 59, 427–443. 
https://doi.org/10.1016/j.addr.2007.04.006. 
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